Activities of LY333328 and Vancomycin Administered Alone or in Combination with Gentamicin against Three Strains of Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacodynamic Infection Model

Documenti analoghi

• Activities of Trovafloxacin and Ampicillin-Sulbactam Alone or in Combination versus Three Strains of Vancomycin- Intermediate Staphylococcus aureus in an In Vitro Pharmacodynamic Infection Model
  di: Aeschlimann, Jeffrey R., et al.
  Pubblicazione: (2000)
• Evaluation of Bactericidal Activities of LY333328, Vancomycin, Teicoplanin, Ampicillin-Sulbactam, Trovafloxacin, and RP59500 Alone or in Combination with Rifampin or Gentamicin against Different Strains of Vancomycin-Intermediate Staphylococcus aureus by Time-Kill Curve Methods
  di: Hershberger, Ellie, et al.
  Pubblicazione: (1999)
• Analysis of Vancomycin Population Susceptibility Profiles, Killing Activity, and Postantibiotic Effect against Vancomycin-Intermediate Staphylococcus aureus
  di: Aeschlimann, Jeffrey R., et al.
  Pubblicazione: (1999)
• Efficacy of LY333328 against Experimental Methicillin-Resistant Staphylococcus aureus Endocarditis
  di: Kaatz, Glenn W., et al.
  Pubblicazione: (1998)
• In Vitro Activities of Daptomycin, Arbekacin, Vancomycin, and Gentamicin Alone and/or in Combination against Glycopeptide Intermediate-Resistant Staphylococcus aureus in an Infection Model
  di: Akins, Ronda L., et al.
  Pubblicazione: (2000)